Literature DB >> 19642048

Prechemotherapy alterations in brain function in women with breast cancer.

Bernadine Cimprich1, Patricia Reuter-Lorenz, James Nelson, Patricia M Clark, Barbara Therrien, Daniel Normolle, Marc G Berman, Daniel F Hayes, Douglas C Noll, Scott Peltier, Robert C Welsh.   

Abstract

Despite clinical reports of cognitive deficits associated with cancer chemotherapy, the underlying brain mechanisms are not clear. This research examined selective attention and working memory using functional magnetic resonance imaging (fMRI) in women before chemotherapy for localized breast cancer. Patients were tested with an established selective attention and working memory task during fMRI. Compared with healthy controls, patients showed (a) bilateral brain activation in high-demand task conditions with recruitment of additional components of attention/working memory circuitry, and (b) less accurate and slower task performance. Results indicate compromised cognitive functioning before any chemotherapy and raise key questions for further research.

Entities:  

Mesh:

Year:  2009        PMID: 19642048     DOI: 10.1080/13803390903032537

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  64 in total

1.  Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study.

Authors:  Brenna C McDonald; Susan K Conroy; Tim A Ahles; John D West; Andrew J Saykin
Journal:  J Clin Oncol       Date:  2012-06-04       Impact factor: 44.544

2.  Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation.

Authors:  Heather S L Jim; Brent Small; Sheri Hartman; Jamie Franzen; Shannon Millay; Kristin Phillips; Paul B Jacobsen; Margaret Booth-Jones; Joseph Pidala
Journal:  Cancer       Date:  2011-12-02       Impact factor: 6.860

Review 3.  Chemotherapy-related cognitive dysfunction.

Authors:  Jeffrey S Wefel; Sanne B Schagen
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

4.  Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study.

Authors:  Brenna C McDonald; Susan K Conroy; Dori J Smith; John D West; Andrew J Saykin
Journal:  Brain Behav Immun       Date:  2012-05-18       Impact factor: 7.217

Review 5.  Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis.

Authors:  Heather L McGinty; Kristin M Phillips; Heather S L Jim; Julie M Cessna; Yasmin Asvat; Mallory G Cases; Brent J Small; Paul B Jacobsen
Journal:  Support Care Cancer       Date:  2014-05-25       Impact factor: 3.603

6.  Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage.

Authors:  Susan K Conroy; Brenna C McDonald; Dori J Smith; Lyndsi R Moser; John D West; Lisa M Kamendulis; James E Klaunig; Victoria L Champion; Frederick W Unverzagt; Andrew J Saykin
Journal:  Breast Cancer Res Treat       Date:  2012-12-22       Impact factor: 4.872

7.  Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors.

Authors:  Jennifer Bruno; S M Hadi Hosseini; Shelli Kesler
Journal:  Neurobiol Dis       Date:  2012-07-20       Impact factor: 5.996

Review 8.  Clearing the air: a review of our current understanding of "chemo fog".

Authors:  Erin O'Farrell; Joyce MacKenzie; Barbara Collins
Journal:  Curr Oncol Rep       Date:  2013-06       Impact factor: 5.075

9.  Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future research.

Authors:  Andrew J Saykin; Michiel B de Ruiter; Brenna C McDonald; Sabine Deprez; Daniel H S Silverman
Journal:  Brain Imaging Behav       Date:  2013-12       Impact factor: 3.978

Review 10.  Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults.

Authors:  Jeffrey S Wefel; Shelli R Kesler; Kyle R Noll; Sanne B Schagen
Journal:  CA Cancer J Clin       Date:  2014-12-05       Impact factor: 508.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.